1887
  1. Home
  2. A-Z Publications
  3. Global Cardiology Science and Practice
  4. Volume 2014, Issue 3
  5. Article
Volume 2014, Issue 3
  • ISSN: 2305-7823
  • EISSN:
Preview this article:
Preview Magnify

© 2014 Widmer, Lerman, licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2014.43
2014-11-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/3/gcsp.2014.43.html?itemId=/content/journals/10.5339/gcsp.2014.43&mimeType=html&fmt=ahah

References

  1. Wolinsky H. A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res. 1980; 47:3:301–311.
     [Google Scholar]
  2. Augustin H, Kozian DH, Johnson RC. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes. Bioessays. 1994; 16:12:901–906.
     [Google Scholar]
  3. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63:25 Pt B:2935–2959.
     [Google Scholar]
  4. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC Jr, Taylor AJ, Weintraub WS, Wenger NK, Jacobs AK, Smith SC Jr, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW, American College of Cardiology Foundation; American Heart Association . 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010; 56:25:e50–e103.
     [Google Scholar]
  5. Go A, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Executive summary: Heart disease and stroke statistics–2013 update: A report from the American Heart Association. Circulation. 2013; 127:1:143–152.
     [Google Scholar]
  6. Janssens S, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992; 267:21:14519–14522.
     [Google Scholar]
  7. Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation. 1997; 96:10:3378–3383.
     [Google Scholar]
  8. Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol. 2001; 38:1:111–116.
     [Google Scholar]
  9. Ford M, McConnell JP, Lavi S, Rihal CS, Prasad A, Sandhu GS, Hartman SJ, Lerman LO, Lerman A. Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy. Atherosclerosis. 2009; 207:1:111–115.
     [Google Scholar]
  10. Lavi S, Prasad A, Yang EH, Mathew V, Simari RD, Rihal CS, Lerman LO, Lerman A. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation. 2007; 115:20:2621–2627.
     [Google Scholar]
  11. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001; 37:6:1523–1528.
     [Google Scholar]
  12. Shinozaki K, Hirayama A, Nishio Y, Yoshida Y, Ohtani T, Okamura T, Masada M, Kikkawa R, Kodama K, Kashiwagi A. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol. 2001; 38:7:1821–1828.
     [Google Scholar]
  13. Arcaro G, Cretti A, Balzano S, Lechi A, Muggeo M, Bonora E, Bonadonna RC. Insulin causes endothelial dysfunction in humans: Sites and mechanisms. Circulation. 2002; 105:5:576–582.
     [Google Scholar]
  14. Balletshofer B, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, Matthaei S, Rett K, Häring HU. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000; 101:15:1780–1784.
     [Google Scholar]
  15. Celermajer D, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 1994; 24:2:471–476.
     [Google Scholar]
  16. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation. 1993; 88:1:77–81.
     [Google Scholar]
  17. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T, Hori S, Yamamoto Y, Doba N, Hinohara S. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement–a survey of 12517 subjects. Atherosclerosis. 2003; 166:2:303–309.
     [Google Scholar]
  18. Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, O'Connor G, Betteridge J, Klein N, Steptoe A, Deanfield JE. Mental Stress Induces Transient Endothelial Dysfunction in Humans. Circulation. 2000; 102:20:2473–2478.
     [Google Scholar]
  19. Martin E, Tan SL, MacBride LR, Lavi S, Lerman LO, Lerman A. Sex differences in vascular and endothelial responses to acute mental stress. Clin Auton Res. 2008; 18:6:339–345.
     [Google Scholar]
  20. Spieker LE, Hürlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S, Hayoz D, Deanfield JE, Lüscher TF, Noll G. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002; 105::2817.
     [Google Scholar]
  21. Poredos P, Kek A. Relation of blunted dilation of the brachial artery in insulin-dependent diabetes mellitus to microalbuminuria. Am J Cardiol. 2000; 86:3:364–367.
     [Google Scholar]
  22. Poredos P, Orehek M, Tratnik E. Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology. 1999; 50:3:201–208.
     [Google Scholar]
  23. Yang Z, Li J, Kong J, Wu S. Impairment of vascular endothelial function following reperfusion therapy in patients with acute myocardial infarction. J Int Med Res. 2013; 41:4:1074–1078.
     [Google Scholar]
  24. Layland J, Judkins C, Palmer S, Whitbourn R, Wilson-O'Brien A, MacIsaac A, Wilson A. The resting status of the coronary microcirculation is a predictor of microcirculatory function following elective PCI for stable angina. Int J Cardiol. 2013; 169:2:121–125.
     [Google Scholar]
  25. Yamamoto M, Hara H, Moroi M, Ito S, Nakamura M, Sugi K. Impaired digital reactive hyperemia and the risk of restenosis after primary coronary intervention in patients with acute coronary syndrome. J Atheroscler Thromb. 2014; 21:9:957–965.
     [Google Scholar]
  26. Gomes V, Gomes MB, Tibirica E, Lessa MA. Post-operative endothelial dysfunction assessment using laser Doppler perfusion measurement in cardiac surgery patients. Acta Anaesthesiol Scand. 2014; 58:4:468–477.
     [Google Scholar]
  27. Feng J, Liu Y, Chu LM, Singh AK, Dobrilovic N, Fingleton JG, Clements RT, Bianchi C, Sellke FW. Changes in microvascular reactivity after cardiopulmonary bypass in patients with poorly controlled versus controlled diabetes. Circulation. 2012; 126:11 Suppl 1:S73–S80.
     [Google Scholar]
  28. Dorbala S, Vangala D, Bruyere J Jr, Quarta C, Kruger J, Padera R, Foster C, Hanley M, Di Carli MF, Falk R. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014; 2:4:358–367.
     [Google Scholar]
  29. Tavares A, Bocchi EA, Guimarães GV. Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: A new frontier. Clinics (Sao Paulo). 2012; 67:3:273–278.
     [Google Scholar]
  30. Yoshino S, Cassar A, Matsuo Y, Herrmann J, Gulati R, Prasad A, Lennon RJ, Lerman LO, Lerman A. Fractional flow reserve with dobutamine challenge and coronary microvascular endothelial dysfunction in symptomatic myocardial bridging. Circ J. 2014; 78:3:685–692.
     [Google Scholar]
  31. Vergnani L, Hatrik S, Ricci F, Passaro A, Manzoli N, Zuliani G, Brovkovych V, Fellin R, Malinski T. Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production: Key role of L-arginine availability. Circulation. 2000; 101:11:1261–1266.
     [Google Scholar]
  32. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: Role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002; 106:24:3073–3078.
     [Google Scholar]
  33. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: Effects of short- and long-term simvastatin treatment. Circulation. 2002; 106:10:1211–1218.
     [Google Scholar]
  34. Li L, Chen W, Rezvan A, Jo H, Harrison DG. Tetrahydrobiopterin deficiency and nitric oxide synthase uncoupling contribute to atherosclerosis induced by disturbed flow. Arterioscler Thromb Vasc Biol. 2011; 31:7:1547–1554.
     [Google Scholar]
  35. Tiefenbacher C, Bleeke T, Vahl C, Amann K, Vogt A, Kübler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation. 2000; 102:18:2172–2179.
     [Google Scholar]
  36. Alexander L, Kutz JL, Kenney WL. Tetrahydrobiopterin increases NO-dependent vasodilation in hypercholesterolemic human skin through eNOS-coupling mechanisms. Am J Physiol Regul Integr Comp Physiol. 2013; 304:2:R164–R169.
     [Google Scholar]
  37. Schulze F, Lenzen H, Hanefeld C, Bartling A, Osterziel KJ, Goudeva L, Schmidt-Lucke C, Kusus M, Maas R, Schwedhelm E, Strödter D, Simon BC, Mügge A, Daniel WG, Tillmanns H, Maisch B, Streichert T, Böger RH. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter coronary artery risk determination investigating the influence of ADMA concentration (CARDIAC) study. Am Heart J. 2006; 152:3:493e1–493e8.
     [Google Scholar]
  38. Böger R, Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin Sci (Lond). 2001; 100:2:161–167.
     [Google Scholar]
  39. Elesber A, Solomon H, Lennon RJ, Mathew V, Prasad A, Pumper G, Nelson RE, McConnell JP, Lerman LO, Lerman A. Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis. Eur Heart J. 2006; 27:7:824–831.
     [Google Scholar]
  40. Valkonen V, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J, Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001; 358:9299:2127–2128.
     [Google Scholar]
  41. Kaye D, Ahlers BA, Autelitano DJ, Chin-Dusting JP. In vivo and in vitro evidence for impaired arginine transport in human heart failure. Circulation. 2000; 102:22:2707–2712.
     [Google Scholar]
  42. Widmer R, Lerman LO, Lerman A. Low-flow motion in the vascular ocean. Circ Cardiovasc Interv. 2012; 5:5:617–619.
     [Google Scholar]
  43. Liuba P, Karnani P, Pesonen E, Paakkari I, Forslid A, Johansson L, Persson K, Wadström T, Laurini R. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice. Circulation. 2000; 102:9:1039–1044.
     [Google Scholar]
  44. Hingorani A, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Donald AE, Palacios M, Griffin GE, Deanfield JE, MacAllister RJ, Vallance P. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000; 102:9:994–999.
     [Google Scholar]
  45. Blum A, Tamir S, Mualem K, Ben-Shushan RS, Keinan-Boker L, Paritsky M. Endothelial dysfunction is reversible in Helicobacter pylori-positive subjects. Am J Med. 2011; 124:12:1171–1174.
     [Google Scholar]
  46. Joensen J, Juul S, Henneberg E, Thomsen G, Ostergaard L, Lindholt JS. Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial. Atherosclerosis. 2008; 196:2:937–942.
     [Google Scholar]
  47. Zahn R, Schneider S, Frilling B, Seidl K, Tebbe U, Weber M, Gottwik M, Altmann E, Seidel F, Rox J, Höffler U, Neuhaus KL, Senges J, Working Group of Leading Hospital Cardiologists . Antibiotic therapy after acute myocardial infarction: A prospective randomized study. Circulation. 2003; 107:9:1253–1259.
     [Google Scholar]
  48. Beckman J, Thakore A, Kalinowski BH, Harris JR, Creager MA. Radiation therapy impairs endothelium-dependent vasodilation in humans. J Am Coll Cardiol. 2001; 37:3:761–765.
     [Google Scholar]
  49. Chow A, Chin C, Dahl G, Rosenthal DN. Anthracyclines cause endothelial injury in pediatric cancer patients: A pilot study. J Clin Oncol. 2006; 24:6:925–928.
     [Google Scholar]
  50. Hollenberg S, Klein LW, Parrillo JE, Scherer M, Burns D, Tamburro P, Bromet D, Satran A, Costanzo MR. Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation. J Heart Lung Transplant. 2004; 23:3:265–271.
     [Google Scholar]
  51. Hasdai D, Holmes DR Jr, Higano ST, Burnett JC Jr, Lerman A. Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain. Mayo Clin Proc. 1998; 73:12:1133–1140.
     [Google Scholar]
  52. Sharaf B, Pepine CJ, Kerensky RA, Reis SE, Reichek N, Rogers WJ, Sopko G, Kelsey SF, Holubkov R, Olson M, Miele NJ, Williams DO, Merz CN, WISE Study Group . Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol. 2001; 87:8:937–941.
     [Google Scholar]
  53. Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis. 2012; 224:2:309–317.
     [Google Scholar]
  54. Sari C, Bayram NA, Doğan FE, Baştuğ S, Bolat AD, Sarı SÖ, Ersoy O, Bozkurt E. The evaluation of endothelial functions in patients with celiac disease. Echocardiography. 2012; 29:4:471–477.
     [Google Scholar]
  55. D'Alessio S, Tacconi C, Fiocchi C, Danese S. Advances in therapeutic interventions targeting the vascular and lymphatic endothelium in inflammatory bowel disease. Curr Opin Gastroenterol. 2013; 29:6:608–613.
     [Google Scholar]
  56. Zelcer S, Chen B, Mangel J, Vujovic O, Thiessen-Philbrook HR, Reider M, Mahmud FH. Impaired vascular function in asymptomatic young adult survivors of Hodgkin Lymphoma following mediastinal radiation. J Cancer Surviv. 2010; 4:3:218–224.
     [Google Scholar]
  57. Targonski P, Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation. 2003; 107:22:2805–2809.
     [Google Scholar]
  58. Targonski P, Caldwell C, Peterson L, Shonyo S, Tangalos E, Lerman A. Association of endothelial dysfunction with cognitive impairment in community dwelling elderly. Abstracts of the 40th Annual Meeting of the Society for Epidemiologic Research, June 19-22, 2007;, Boston, Massachusetts, USA. Am J Epidemiol. 2007 Jun 1;165(11 Suppl):S1–S151.
     [Google Scholar]
  59. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation. 2009; 120:6:502–509.
     [Google Scholar]
  60. Huang A, Silver AE, Shvenke E, Schopfer DW, Jahangir E, Titas MA, Shpilman A, Menzoian JO, Watkins MT, Raffetto JD, Gibbons G, Woodson J, Shaw PM, Dhadly M, Eberhardt RT, Keaney JF Jr, Gokce N, Vita JA. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol. 2007; 27:10:2113–2119.
     [Google Scholar]
  61. Anderson T, Charbonneau F, Title LM, Buithieu J, Rose MS, Conradson H, Hildebrand K, Fung M, Verma S, Lonn EM. Microvascular function predicts cardiovascular events in primary prevention: Long-term results from the firefighters and their endothelium (FATE) study. Circulation. 2011; 123:2:163–169.
     [Google Scholar]
  62. Lind L, Berglund L, Larsson A, Sundström J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation. 2011; 123:14:1545–1551.
     [Google Scholar]
  63. Huang P, Chen LC, Leu HB, Ding PY, Chen JW, Wu TC, Lin SJ. Enhanced coronary calcification determined by electron beam CT is strongly related to endothelial dysfunction in patients with suspected coronary artery disease. Chest. 2005; 128:2:810–815.
     [Google Scholar]
  64. Ramadan M, Mahfouz EM, Gomaa GF, El-Diasty TA, Alldawi L, Ikrar T, Limin D, Kodama M, Aizawa Y. Evaluation of coronary calcium score by multidetector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals. Circ J. 2008; 72:5:778–785.
     [Google Scholar]
  65. Ludmer P, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986; 315:17:1046–1051.
     [Google Scholar]
  66. Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000; 101:9:948–954.
     [Google Scholar]
  67. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000; 101:16:1899–1906.
     [Google Scholar]
  68. Shaw L, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE, COURAGE Investigators . Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation. 2008; 117:10:1283–1291.
     [Google Scholar]
  69. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF, FAME Study Investigators . Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009; 360:3:213–224.
     [Google Scholar]
  70. Muller O, Mangiacapra F, Ntalianis A, Verhamme KM, Trana C, Hamilos M, Bartunek J, Vanderheyden M, Wyffels E, Heyndrickx GR, van Rooij FJ, Witteman JC, Hofman A, Wijns W, Barbato E, De Bruyne B. Long-term follow-up after fractional flow reserve-guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis. JACC Cardiovasc Interv. 2011; 4:11:1175–1182.
     [Google Scholar]
  71. Fearon W, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003; 107:25:3129–3132.
     [Google Scholar]
  72. McGeoch R, Watkins S, Berry C, Steedman T, Davie A, Byrne J, Hillis S, Lindsay M, Robb S, Dargie H, Oldroyd K. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010; 3:7:715–722.
     [Google Scholar]
  73. Celermajer D, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992; 340:8828:1111–1115.
     [Google Scholar]
  74. Anderson T, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995; 26:5:1235–1241.
     [Google Scholar]
  75. Betik A, Luckham VB, Hughson RL. Flow-mediated dilation in human brachial artery after different circulatory occlusion conditions. Am J Physiol Heart Circ Physiol. 2004; 286:1:H442–H458.
     [Google Scholar]
  76. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001; 104:2:191–196.
     [Google Scholar]
  77. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: A meta-analysis. Int J Cardiovasc Imaging. 2010; 26:6:631–640.
     [Google Scholar]
  78. Peters S, den Ruijter HM, Bots ML, Moons KG. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: A systematic review. Heart. 2012; 98:3:177–184.
     [Google Scholar]
  79. Thijssen D, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011; 300:1:H2–H12.
     [Google Scholar]
  80. Lekakis J, Abraham P, Balbarini A, Blann A, Boulanger CM, Cockcroft J, Cosentino F, Deanfield J, Gallino A, Ikonomidis I, Kremastinos D, Landmesser U, Protogerou A, Stefanadis C, Tousoulis D, Vassalli G, Vink H, Werner N, Wilkinson I, Vlachopoulos C. Methods for evaluating endothelial function: A position statement from the european society of cardiology working group on peripheral circulation. Eur J Cardiovasc Prev Rehabil. 2011; 18:6:775–789.
     [Google Scholar]
  81. Mather K, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol. 2001; 37:5:1344–1350.
     [Google Scholar]
  82. Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, Parker JD. Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol. 2008; 51:20:1953–1958.
     [Google Scholar]
  83. Gori T, Muxel S, Damaske A, Radmacher MC, Fasola F, Schaefer S, Schulz A, Jabs A, Parker JD, Münzel T. Endothelial function assessment: Flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J. 2012; 33:3:363–371.
     [Google Scholar]
  84. Bellien J, Joannides R, Iacob M, Arnaud P, Thuillez C. Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans. Am J Physiol Heart Circ Physiol. 2006; 290:4:H1347–H1352.
     [Google Scholar]
  85. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2009; 2:4:302–308.
     [Google Scholar]
  86. Gori T, Parker JD, Münzel T. Flow-mediated constriction: Further insight into a new measure of vascular function. Eur Heart J. 2011; 32:7:784–787.
     [Google Scholar]
  87. Spiro J, Digby JE, Ghimire G, Mason M, Mitchell AG, Ilsley C, Donald A, Dalby MC, Kharbanda RK. Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: Characterization of a recently described index of vascular function. Eur Heart J. 2011; 32:7:856–866.
     [Google Scholar]
  88. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004; 44:11:2137–2141.
     [Google Scholar]
  89. Hasdai D, Lerman A. The assessment of endothelial function in the cardiac catheterization laboratory in patients with risk factors for atherosclerotic coronary artery disease. Herz. 1999; 24:7:544–547.
     [Google Scholar]
  90. Goor DA, Sheffy J, Schnall RP, Arditti A, Caspi A, Bragdon EE, Sheps DS. Peripheral arterial tonometry: A diagnostic method for detection of myocardial ischemia induced during mental stress tests: A pilot study. Clin Cardiol. 2004; 27:3:137–141.
     [Google Scholar]
  91. Lerman A, A M. Zeiher. Endothelial function: Cardiac events. Circulation. 2005; 111:3:363–368.
     [Google Scholar]
  92. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004; 44:11:2137–2141.
     [Google Scholar]
  93. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 2006; 101:2:545–548.
     [Google Scholar]
  94. Kuvin J, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003; 146:1:168–174.
     [Google Scholar]
  95. Hamburg N, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, Levy D, Mitchell GF, Vita JA, Benjamin EJ. Relation of brachial and digital measures of vascular function in the community: The Framingham heart study. Hypertension. 2011; 57:3:390–396.
     [Google Scholar]
  96. Schnabel R, Schulz A, Wild PS, Sinning CR, Wilde S, Eleftheriadis M, Herkenhoff S, Zeller T, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Münzel T. Noninvasive vascular function measurement in the community: Cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging. 2011; 4:4:371–380.
     [Google Scholar]
  97. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 1985; 101:2:545–548.
     [Google Scholar]
  98. Modena M, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol. 2002; 40::505–510.
     [Google Scholar]
  99. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, Saito Y, Kawabata K, Sano K, Kobayashi T, Yano T, Nakamura K, Kugiyama K. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009; 53:4:323–330.
     [Google Scholar]
  100. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010; 31:9:1142–1148.
     [Google Scholar]
  101. Kjaer A, Meyer C, Nielsen FS, Parving HH, Hesse B. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: A PET study of myocardial perfusion in diabetes. J Nucl Med. 2003; 44:1:19–23.
     [Google Scholar]
  102. Johnson N, Gould KL. Clinical evaluation of a new concept: Resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects. J Nucl Med. 2005; 46:9:1427–1437.
     [Google Scholar]
  103. Wöhrle J, Nusser T, Merkle N, Kestler HA, Grebe OC, Marx N, Höher M, Kochs M, Hombach V. Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction. J Cardiovasc Magn Reson. 2006; 8:6:781–787.
     [Google Scholar]
  104. Yilmaz A, Athanasiadis A, Mahrholdt H, Voehringer M, Ong P, Hill S, Kispert EM, Seebo M, Sechtem U. Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing. Heart. 2010; 96:5:372–379.
     [Google Scholar]
  105. Wenzel R, Duthiers N, Noll G, Bucher J, Kaufmann U, Lüscher TF. Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Circulation. 1996; 94:3:316–322.
     [Google Scholar]
  106. Deyoung L, Chung E, Kovac JR, Romano W, Brock GB. Daily use of sildenafil improves endothelial function in men with type 2 diabetes. J Androl. 2012; 33:2:176–180.
     [Google Scholar]
  107. Vardi Y, Appel B, Ofer Y, Greunwald I, Dayan L, Jacob G. Effect of chronic sildenafil treatment on penile endothelial function: A randomized, double-blind, placebo controlled study. J Urol. 2009; 182:6:2850–2855.
     [Google Scholar]
  108. Redfield M, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E, RELAX Trial. and Collaborators . Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial. JAMA. 2013; 309:12:1268–1277.
     [Google Scholar]
  109. Ishibashi Y, Takahashi N, Tokumaru A, Karino K, Sugamori T, Sakane T, Yoshitomi H, Sato H, Oyake N, Murakami Y, Shimada T. Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease. J Cardiovasc Pharmacol. 2008; 51:3:311–316.
     [Google Scholar]
  110. Izumiya Y, Kojima S, Kojima S, Araki S, Usuku H, Matsubara J, Sakamoto K, Tsujita K, Nagayoshi Y, Kaikita K, Sugiyama S, Ogawa H. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris. Atherosclerosis. 2011; 214:2:415–421.
     [Google Scholar]
  111. Lüscher T, Pieper M, Tendera M, Vrolix M, Rutsch W, van den Branden F, Gil R, Bischoff KO, Haude M, Fischer D, Meinertz T, Münzel T. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: The ENCORE II study. Eur Heart J. 2009; 30:13:1590–1597.
     [Google Scholar]
  112. Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, Di Monaco A, Sarullo FM, Lanza GA, Crea F. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol. 2013; 112:1:8–13.
     [Google Scholar]
  113. Lamendola P, Nerla R, Pitocco D, Villano A, Scavone G, Stazi A, Russo G, Di Franco A, Sestito A, Ghirlanda G, Lanza GA, Crea F. Effect of ranolazine on arterial endothelial function in patients with type 2 diabetes mellitus. Atherosclerosis. 2013; 226:1:157–160.
     [Google Scholar]
  114. Deshmukh S, Patel SR, Pinassi E, Mindrescu C, Hermance EV, Infantino MN, Coppola JT, Staniloae CS. Ranolazine improves endothelial function in patients with stable coronary artery disease. Coron Artery Dis. 2009; 20:5:343–347.
     [Google Scholar]
  115. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, Minagoe S, Toyama Y, Tei C. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol. 2001; 38:4:1083–1088.
     [Google Scholar]
  116. Bonetti P, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23:2:168–175.
     [Google Scholar]
  117. Tiefenbacher C, Friedrich S, Bleeke T, Vahl C, Chen X, Niroomand F. ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles. Am J Physiol Heart Circ Physiol. 2004; 286:4:425–432.
     [Google Scholar]
  118. Moertl D, Hammer A, Steiner S, Hutuleac R, Vonbank K, Berger R. Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: A double-blind, placebo-controlled, 3-arm study. Am Heart J. 2011; 161:5:e1–e9.
     [Google Scholar]
  119. Evans M, Anderson RA, Graham J, Ellis GR, Morris K, Davies S, Jackson SK, Lewis MJ, Frenneaux MP, Rees A. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation. 2000; 101:15:1773–1779.
     [Google Scholar]
  120. Sahebkar A. Effect of niacin on endothelial function: A systematic review and meta-analysis of randomized controlled trials. Vasc Med. 2014; 19:1:54–66.
     [Google Scholar]
  121. Anderson T, Elstein E, Haber H, Charbonneau F. Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study). J Am Coll Cardiol. 2000; 35:1:60–66.
     [Google Scholar]
  122. Mancini G, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine CJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996; 94:3:258–265.
     [Google Scholar]
  123. Prasad A, Tupas-Habib T, Schenke WH, Mincemoyer R, Panza JA, Waclawin MA, Ellahham S, Quyyumi AA. Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation. 2000; 101:20:2349–2354.
     [Google Scholar]
  124. Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: Role of superoxide dismutase. Circulation. 2001; 103:6:799–805.
     [Google Scholar]
  125. Cheetham C, Collis J, O'Driscoll G, Stanton K, Taylor R, Green D. Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol. 2000; 36:5:1461–1466.
     [Google Scholar]
  126. Hinoi T, Tomohiro Y, Kajiwara S, Matsuo S, Fujimoto Y, Yamamoto S, Shichijo T, Ono T. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. Hypertens Res. 2008; 31:4:615–622.
     [Google Scholar]
  127. Virdis A, Ghiadoni L, Qasem AA, Lorenzini G, Duranti E, Cartoni G, Bruno RM, Bernini G, Taddei S. Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients. Eur Heart J. 2012; 33:12:1530.
     [Google Scholar]
  128. Zepeda R, Castillo R, Rodrigo R, Prieto JC, Aramburu I, Brugere S, Galdames K, Noriega V, Miranda HF. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension. Basic Clin Pharmacol Toxicol. 2012; 111:5:309–316.
     [Google Scholar]
  129. Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 1998; 97:8:716–720.
     [Google Scholar]
  130. Andrews N, Prasad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol. 2001; 37:1:117–123.
     [Google Scholar]
  131. Gilligan D, Quyyumi AA, Cannon ROIII. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994; 89:6:2543–2551.
     [Google Scholar]
  132. Venkov C, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996; 94:4:727–733.
     [Google Scholar]
  133. Thompson L, Pinkas G, Weiner CP. Chronic 17beta-estradiol replacement increases nitric oxide-mediated vasodilation of guinea pig coronary microcirculation. Circulation. 2000; 102:4:445–451.
     [Google Scholar]
  134. Webb C, Ghatei MA, McNeill JG, Collins P. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation. 2000; 102:14:1617–1622.
     [Google Scholar]
  135. Clarke S, Schofield PM, Grace AA, Metcalfe JC, Kirschenlohr HL. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. Circulation. 2001; 103:11:1497–1502.
     [Google Scholar]
  136. Webb C, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999; 100:16:1690–1696.
     [Google Scholar]
  137. Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, Lennon R, Rihal C, Lerman LO, Lerman A. Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation. 2010; 122:10:958–966.
     [Google Scholar]
  138. Vitale C, Mercuro G, Cornoldi A, Fini M, Volterrani M, Rosano GM. Metformin improves endothelial function in patients with metabolic syndrome. J Intern Med. 2005; 258:3:250–256.
     [Google Scholar]
  139. Jensterle M, Sebestjen M, Janez A, Prezelj J, Kocjan T, Keber I, Pfeifer M. Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome. Eur J Endocrinol. 2008; 159:4:399–406.
     [Google Scholar]
  140. Mittermayer F, Schaller G, Pleiner J, Krzyzanowska K, Kapiotis S, Roden M, Wolzt M. Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunction. J Clin Endocrinol Metab. 2007; 92:7:2574–2580.
     [Google Scholar]
  141. Irat A, Aslamaci S, Karasu C, Ari N. Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones. J Pharm Pharmacol. 2006; 58:12:1647–1653.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2014.43
Loading
Endothelial dysfunction and cardiovascular disease
Global Cardiology Science and Practice 2014, 43 (2014); https://doi.org/10.5339/gcsp.2014.43
/content/journals/10.5339/gcsp.2014.43
/content/journals/10.5339/gcsp.2014.43
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error